Inventor

De-Yi Yang

Inventor
Morris Plains, NJ, US

Overview

21→
Patents
2009–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds29%
A61KPreparations for medical, dental or toiletry purposes22%
Y02ATechnologies for adaptation to climate change6%
C12NMicroorganisms or enzymes3%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%
C02FTreatment of water, waste water, sewage, or sludge2%
C08HDerivatives of natural macromolecular compounds2%
C08LCompositions of macromolecular compounds2%
Y02WClimate change mitigation technologies related to wastewater treatment or waste management2%
PatentTitleYear
11,059,031Three-dimensional lignin porous carbon/zinc oxide composite material and its preparation and application in the field of photocatalysis202110,646,494Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases202010,519,115Antidiabetic tricyclic compounds20199,567,566'HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants'20178,859,529'Compounds for the treatment of inflammatory disorders'20148,569,336'Compounds for the treatment of inflammatory disorders'20138,541,572'Compounds for the treatment of inflammatory disorders'20138,450,355'Compounds for the treatment of inflammatory diseases'20138,361,959'Spiro-imidazolone derivatives as glucagon receptor antagonists'20138,227,417'HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants'20128,178,553'Compounds for the treatment of inflammatory disorders'20127,879,890'Compounds for the treatment of inflammatory disorders'20117,879,838'Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity'20117,772,263'Compounds for the treatment of inflammatory disorders'20107,687,527'Compounds for the treatment of inflammatory disorders'20107,683,088'Compounds for the treatment of inflammatory disorders'20107,683,085'Compounds for the treatment of inflammatory disorders'20107,524,842'Compounds for the treatment of inflammatory disorders'20097,504,424'Compounds for the treatment of inflammatory disorders'20097,488,745'Compounds for the treatment of inflammatory disorders'20097,482,370'Compounds for the treatment of inflammatory disorders'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2012Patents assigned to SCHERING CORP (11)· patent assignee history
2009–2020Based in Morris Plains, NJ, US· patent location history
2012–2014Patents assigned to KOZLOWSKI JOSEPH A (6)· patent assignee history
2012–2014Patents assigned to LAVEY BRIAN J (6)· patent assignee history
2012–2014Patents assigned to WONG MICHAEL K C (6)· patent assignee history
2012–2017Based in Frederick, MD, US· patent location history
2013–2020Patents assigned to MERCK SHARP & DOHME (6)· patent assignee history
2021Based in Guangzhou, CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SCHERING CORP112009–2012
KOZLOWSKI JOSEPH A62012–2014
LAVEY BRIAN J62012–2014
MERCK SHARP & DOHME62013–2020
WONG MICHAEL K C62012–2014
Locations
LocationPatentsSpan
Morris Plains, New Jersey, US182009–2020
Frederick, Maryland, US22012–2017
Guangzhou, CN12021